Back to AMERICAN CENTURY COMPANIES INC AMERICAN CENTURY COMPANIES INC

CLDXCLDX
Showing 8 of 19 quarters

Position history for AMERICAN CENTURY COMPANIES INCAMERICAN CENTURY COMPANIES INC's holdings in Celldex Therapeutics, Inc.

AMERICAN CENTURY COMPANIES INC holds 1M shares of CLDX (Celldex Therapeutics, Inc.), worth $38.8M as of 2026-Q2. The position was increased (+21.7% shares). CLDX represents 0.0% of AMERICAN CENTURY COMPANIES INC's portfolio.

Current Value

$38.8M

Current Shares

1M

Total Value Change

+$24.7M

Total Shares Change

+627,031

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+21.7%
$38.8M0.0%$37.21
35
2026-Q1
Increased
856,310
+0.1%
$27.2M0.0%$28.94
29
2025-Q4
Increased
855,226
+4.9%
$23.2M0.0%$26.43
30
2025-Q3
Increased
815,560
+4.6%
$21.1M0.0%$26.19
30
2025-Q2
Increased
779,985
+24.7%
$15.9M0.0%$20.29
34
2025-Q1
Increased
625,321
+2.8%
$11.3M0.0%$19.93
29
2024-Q4
Increased
608,457
+46.5%
$15.4M0.0%$25.12
38
2024-Q3
Decreased
415,364
-0.1%
$14.1M0.0%$33.20
0

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used